-
1
-
-
69249219296
-
Association of cytochrome P450 2 C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy
-
Shuldiner AR, O'Connell JR, Bliden KP, et al. Association of cytochrome P450 2 C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA 2009;302:849-57.
-
(2009)
JAMA
, vol.302
, pp. 849-857
-
-
Shuldiner, A.R.1
O'Connell, J.R.2
Bliden, K.P.3
-
2
-
-
58749094444
-
Cytochrome P-450 polymorphisms and response to clopidogrel
-
Mega JL, Close SL, Wiviott SD, et al. Cytochrome P-450 polymorphisms and response to clopidogrel. N Engl J Med 2009;360:354-62.
-
(2009)
N Engl J Med
, vol.360
, pp. 354-362
-
-
Mega, J.L.1
Close, S.L.2
Wiviott, S.D.3
-
3
-
-
33750079553
-
Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin [8]
-
DOI 10.1111/j.1538-7836.2006.02162.x
-
Gilard M, Arnaud B, Le Gal G, Abgrall JF, Boschat J. Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin. J Thromb Haemost 2006;4:2508-9. (Pubitemid 44575451)
-
(2006)
Journal of Thrombosis and Haemostasis
, vol.4
, Issue.11
, pp. 2508-2509
-
-
Gilard, M.1
Arnaud, B.2
Le, G.G.3
Abgrall, J.F.4
Boschat, J.5
-
4
-
-
38349065084
-
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: The randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study
-
Gilard M, Arnaud B, Cornily JC, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Colloid Cardiol 2008;51:256-60.
-
(2008)
J Am Colloid Cardiol
, vol.51
, pp. 256-260
-
-
Gilard, M.1
Arnaud, B.2
Cornily, J.C.3
-
5
-
-
78650739879
-
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: A focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents
-
Abraham NS, Hlatky MA, Antman EM, et al. ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation 2010;122:2619-33.
-
(2010)
Circulation
, vol.122
, pp. 2619-2633
-
-
Abraham, N.S.1
Hlatky, M.A.2
Antman, E.M.3
-
6
-
-
61549124132
-
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome
-
Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009;301:937-44.
-
(2009)
JAMA
, vol.301
, pp. 937-944
-
-
Ho, P.M.1
Maddox, T.M.2
Wang, L.3
-
7
-
-
70249139788
-
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: An analysis of two randomised trials
-
O'Donoghue ML, Braunwald E, Antman EM, et al. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. Lancet 2009;374:989-97.
-
(2009)
Lancet
, vol.374
, pp. 989-997
-
-
O'Donoghue, M.L.1
Braunwald, E.2
Antman, E.M.3
-
8
-
-
78149487926
-
Clopidogrel with or without omeprazole in coronary artery disease
-
COGENT Investigators
-
Bhatt DL, Cryer BL, Contant CF, et al, COGENT Investigators. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 2010;363:1909-17.
-
(2010)
N Engl J Med
, vol.363
, pp. 1909-1917
-
-
Bhatt, D.L.1
Cryer, B.L.2
Contant, C.F.3
-
9
-
-
37849002889
-
Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
-
Wallentin L, Varenhorst C, James S, et al. Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. Eur Heart J 2008;29:21-30.
-
(2008)
Eur Heart J
, vol.29
, pp. 21-30
-
-
Wallentin, L.1
Varenhorst, C.2
James, S.3
-
10
-
-
73849084548
-
Proton pump inhibitor and clopidogrel interaction: Fact or fiction?
-
Laine L, Hennekens C. Proton pump inhibitor and clopidogrel interaction: fact or fiction? Am J Gastroenterol 2010;105:34-41.
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 34-41
-
-
Laine, L.1
Hennekens, C.2
-
11
-
-
78650113666
-
Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: Results of a prospective randomized crossover study
-
Ferreiro JL, Ueno M, Capodanno D, et al. Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover study. Circ Cardiovasc Interv 2010;3:436-41.
-
(2010)
Circ Cardiovasc Interv
, vol.3
, pp. 436-441
-
-
Ferreiro, J.L.1
Ueno, M.2
Capodanno, D.3
-
12
-
-
0142162559
-
Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects
-
DOI 10.1067/mcp.2003.14
-
Chen XP, Tan ZR, Huang SL, Huang Z, Ou-Yang DS, Zhou HH. Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects. Clin Pharmacol Ther 2003;73:264-71. (Pubitemid 36269677)
-
(2003)
Clinical Pharmacology and Therapeutics
, vol.73
, Issue.3
, pp. 264-271
-
-
Chen, X.-P.1
Tan, Z.-R.2
Huang, S.-L.3
Huang, Z.4
Ou-Yang, D.-S.5
Zhou, H.-H.6
-
13
-
-
38349090725
-
Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment
-
Sibbing D, Braun S, Jawansky S, et al. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008;99:121-6.
-
(2008)
Thromb Haemost
, vol.99
, pp. 121-126
-
-
Sibbing, D.1
Braun, S.2
Jawansky, S.3
-
14
-
-
74749094606
-
Multiple electrode aggregometry better predicts stent thrombosis than the VASP assay
-
Siller-Matula JM, Christ G, Lang IM, Delle-Karth G, Huber K, Jilma B. Multiple electrode aggregometry better predicts stent thrombosis than the VASP assay. J Thromb Haemost 2010;8:351-9.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 351-359
-
-
Siller-Matula, J.M.1
Christ, G.2
Lang, I.M.3
Delle-Karth, G.4
Huber, K.5
Jilma, B.6
-
15
-
-
77957884628
-
Ethics in the authorship and publishing of scientific articles
-
Shewan LG, Coats AJ. Ethics in the authorship and publishing of scientific articles. Int J Cardiol 2010;144:1-2.
-
(2010)
Int J Cardiol
, vol.144
, pp. 1-2
-
-
Shewan, L.G.1
Coats, A.J.2
|